Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-12 Sale | 2021-08-12 9:33 pm | TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer | 93,337 | $0.87 | $81,203 | 558,163 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-01 Option Award | 2023-08-03 2:01 pm | N/A N/A | Prestige Consumer Healthcare Inc. | PBH | DArecca James Director | 2,295 | $0 | 2,295 (Direct) | View |
| 2023-05-16 Tax Withholding | 2023-05-17 4:26 pm | N/A N/A | HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer | 349 | $89.21 | 23,604 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 4:26 pm | N/A 2030-05-15 | HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer | 13,707 | $0 | 23,604 (Direct) | View |
| 2023-05-02 Tax Withholding | 2023-05-04 4:27 pm | N/A N/A | HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer | 430 | $81.66 | 10,246 (Direct) | View |
| 2022-05-16 Option Award | 2022-05-18 4:34 pm | N/A 2029-05-16 | HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer | 15,937 | $0 | 21,839 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 4:41 pm | N/A 2029-05-02 | HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer | 19,730 | $0 | 19,730 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-12 9:33 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer | 217,167 | $0 | 558,163 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:45 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | DArecca James CFO | 520,000 | $0 | 520,000 (Direct) | View |
| 2020-06-18 Option Award(A) | 2020-08-07 9:16 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer | 803,000 | $0 | 803,000 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-19 5:07 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer | 803,000 | $0 | 803,000 (Direct) | View |
| 2020-05-08 Disposition | 2020-05-11 9:50 pm | N/A 2023-07-17 | Allergan plc | AGN | DArecca James SVP Chief Accounting Officer | 19,495 | $0 | 0 (Direct) | View |
| 2020-03-06 Tax Withholding | 2020-03-10 2:10 pm | N/A N/A | Allergan plc | AGN | DArecca James SVP Chief Accounting Officer | 718 | $191.95 | 9,834 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 2:22 pm | N/A N/A | Allergan plc | AGN | DArecca James SVP Chief Accounting Officer | 3,611 | $193.84 | 10,552 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-02 5:52 pm | N/A N/A | Allergan plc | AGN | DArecca James SVP Chief Accounting Officer | 92 | $191.17 | 6,941 (Direct) | View |